Abstract
Background
The purpose of this study was to assess the impact of hormone therapy on post-implant dosimetry in patients in whom pre-plan and interactive-plan techniques were used for transperineal brachytherapy against prostatic cancer.
Methods
The subjects comprised 244 patients treated using 125I seed implantation as monotherapy. The prescribed dose to the periphery of the prostate was 145 Gy. The pre-plan technique was used for 116 patients, and the interactiveplan technique for 128 patients. Hormone therapy was used in 71 patients (29.1%). The D90 (dose to 90% of prostate volume) of post-implant computed tomography (CT) analysis was assessed in both groups. In addition, the ratio of post-implant CT volume to preoperative ultrasonography (US) volume was assessed.
Results
In the pre-plan group, D90 was significantly lower for patients who received hormone therapy than for those who did not (P = 0.035). However, in the interactive-plan group, D90 did not differ between patients with and without hormone therapy (P = 0.467). The CT-to-US prostate volume ratio was 1.022 for patients who received hormone therapy and 0.960 for patients who did not (P = 0.021).
Conclusion
Post-traumatic swelling following implantation is increased by cessation of hormone therapy and may reduce D90. However, the present results suggest that the interactive-plan technique overcomes this disadvantage of hormone therapy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Kucway R, Vicini F, Huang R, et al. (2002) Prostate volume reduction with androgen deprivation therapy before interstitial brachytherapy. J Urol 167:2443–2447
Whittington R, Broderick GA, Arger P, et al. (1999) The effect of androgen deprivation on the early changes in prostate volume following transperineal ultrasound guided interstitial therapy for localized carcinoma of the prostate. Int J Radiat Oncol Biol Phys 44:1107–1110
Ash D, Al-Qaisieh B, Bottomley D, et al. (2005) The impact of hormone therapy on post-implant dosimetry and outcome following iodine-125 implant monotherapy for localized prostate cancer. Radiother Oncol 75:303–306
Stock RG, Stone NN, Wesson MF, et al. (1995) A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation. Int J Radiat Oncol Biol Phys 32:219–225
Waterman FM, Yue N, Corn BW, et al. (1998) Edema associated with I-125 or Pd-103 prostate brachytherapy and its impact on post-implant dosimetry: an analysis based on serial CT acquisition. Int J Radiat Oncol Biol Phys 41:1069–1077
Prestidge BR, Bice WS, Kiefer EJ, Prete JJ (1998) Timing of computed tomography-based postimplant assessment following terminal transperineal prostate brachytherapy. Int J Radiat Oncol Biol Phys 40:1111–1115
Badiozamani KR, Wallner K, Cavanagh W, et al. (1999) Comparability of CT-based and TRUS-based prostate volumes. Int J Radiat Oncol Biol Phys 43:375–378
Dogan N, Mohideen N, Glasgow GP, et al. (2002) Effect of prostatic edema on CT-based postimplant dosimetry. Int J Radiat Oncol Biol Phys 53:483–489
Merrick GS, Butler WM, Dorsey AT, et al. (1999) The dependence of prostate postimplant dosimetric quality on CT volume determination. Int J Radiat Oncol Biol Phys 44:1111–1117
Taussky D, Austen L, Toi A, et al. (2005) Sequential evaluation of prostate edema after permanent seed prostate brachytherapy using CT-MRI fusion. Int J Radiat Oncol Biol Phys 62:974–980
Aoki M, Miki K, Takahashi H, et al. (2005) Changes of edema associated with I-125 prostate brachytherapy (in Japanese). Nippon Igaku Hoshasen Gakkai Zasshi 65:411–418
Solhjem MC, Davis BJ, Pisansky TM, et al. (2004) Prostate volume before and after permanent prostate brachytherapy in patients receiving neoadjuvant androgen suppression. Cancer J 10:343–348
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Ishiyama, H., Satoh, T., Kitano, M. et al. Interactive-plan technique conquers the disadvantages of volume-reducing hormone therapy in 125I permanent implantation for localized prostate cancer. Int J Clin Oncol 14, 53–55 (2009). https://doi.org/10.1007/s10147-008-0799-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10147-008-0799-6